2 Healthcare Stocks That Could Soar Over the Next 5 Years [Yahoo! Finance]
Abivax SA (ABVX)
Company Research
Source: Yahoo! Finance
decent chance it will still perform fairly well over the next five years. That's what we have come to expect from equities, given their track record over the past decades. So, it might still be a good idea to invest in stocks right now, but not just any will do. Let's consider two healthcare companies that have the potential to perform better than broader equities through the next half a decade: Moderna (NASDAQ: MRNA) and Abivax (NASDAQ: ABVX) Image source: Getty Images. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » 1. Moderna Moderna's shares could soar as it advances its mRNA platform. Compared to older vaccines, those of the mRNA variety have advantages, including being much faster to produce and sometimes eliciting stronger, more targeted immune responses. Moderna was able to develop and market a coron
Show less
Read more
Impact Snapshot
Event Time:
ABVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABVX alerts
High impacting Abivax SA news events
Weekly update
A roundup of the hottest topics
ABVX
News
- Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory AgenciesGlobeNewswire
- Abivax (ABVX) had its price target raised by Barclays PLC from $142.00 to $148.00. They now have an "overweight" rating on the stock.MarketBeat
- Abivax Announces Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
- Abivax (ABVX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $160.00 price target on the stock.MarketBeat
- Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year [Yahoo! Finance]Yahoo! Finance